Cardiovascular Complications From COVID-19 Rose as Pandemic Wore On
Cardiovascular complications from COVID-19 increased from 7% in March 2020 to nearly 10% in December 2021
Diagnosis & Disease Information
Erectile Dysfunction Drugs Shown to Prevent Major Adverse Cardiovascular Events
The cardioprotective effect was more pronounced with tadalafil than sildenafil.
Long-Term PM₂.₅ Exposure Linked to Increased Risk for Cardiovascular Events
Increased risk for incident AMI, IHD mortality seen with exposure to PM2.5 at moderate versus low concentrations
Kidney Biopsy Findings Predict Risk of Cardiovascular Events in CKD
Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.
Radical Cystectomy Increases Risks for Thromboembolic Events
Swedish studies reveal significantly elevated risks for myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis.
AMI, Stroke Risk Elevated for Women With Preeclampsia Within 20 Years
Rates of AMI and stroke remained doubled more than 20 years after delivery; increased rates also seen for women aged 30 to 39 years
Invasive Cardiac Care Less Likely in Veterans With CKD
Inadequately treated acute coronary syndrome can result in heart failure and early death.
Biomarker Improves Prediction of Major Bleeding in Hemodialysis Population
GDF-15 adds predictive value to the HAS-BLED score for assessing major bleeding risk.
Post-Transplant Anemia Tied With Adverse Kidney, Cardiovascular Outcomes
According to investigators, it is crucial to find the underlying causes of post-transplant anemia and to treat all reversible causes.
SGLT2 Inhibitor Plus MRA May Further Reduce Cardiovascular Risks
SGLT2 inhibitors and MRAs might provide complementary effects for organ protection, according to investigators.
- Loading...
Loading...
Next post in Hyperkalemia
Loading... 
Loading...